Green Valley Drugs Recalls Methylcobalamin Injections Due to Sterility Concerns
Green Valley Drugs is recalling 1,343 vials of Methylcobalamin Injection nationwide because the pharmacy could not ensure the products were sterile.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of sterility assurance for injectable drugs, which poses a significant risk of serious injury or infection.
Plain-English summary
FVS Holdings, Inc. dba. Green Valley Drugs is recalling 1,343 vials of Methylcobalamin Injection, prescription only, in various strengths and presentations. The recall covers all sterile products compounded, repackaged, and distributed by this compounding pharmacy.
The recall was initiated due to a lack of assurance of sterility and concerns associated with the quality control processes. The affected products were distributed nationwide.
Consumers and healthcare providers should stop using the recalled products and contact their healthcare provider for further instructions.
The recalled product
- Product
- Methylcobalamin Injection, all strengths and all presentations including a) Methylcobalamin 1000 mcg/mL in 10 mL, 30 mL, 50 mL, 60 mL, b) Methylcobalamin 1000 mcg 30 mL, c) Methylcobalamin 5 mg/mL 30 mL, d) Methylcobalamin PF 1000 mcg/mL in 2 mL, 5 mL, 10 mL, Rx only, Green…
- Manufacturer
- FVS Holdings, Inc. dba. Green Valley Drugs
- Category
- Drug — Injectable
- Affected units
- 1,343
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: a) Methylcobalamin 1000 mcg: 20130208-G
- Exp 5/8/2013
- 20130118-G
- Exp 4/18/2013
- 20130129-E
- Exp 4/29/2013
- 20130212-B
- Exp 5/12/2013
- 20130221-I
- Exp 5/21/2013
- 20130206-D
- Exp 5/6/2013
- 20130301-E
- Exp 6/1/2013
- 20130305-C
- Exp 6/5/2013
- b) Methylcobalamin 1000 mcg 30 mL: 20130308-G
- Exp 6/8/2013
- c) Methylcobalamin 5 mg/30 mL: 20130214-I
- Exp 5/14/2013
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 78 recalled by FVS Holdings, Inc. dba. Green Valley Drugs under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 78 products in this recall →Related recalls
Same manufacturer · FVS Holdings, Inc. dba. Green Valley Drugs
See all →- SevereGreen Valley Drugs Recalls Phosphatidylcholine Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereFDA Recalls Acetylcysteine Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Thiamine Hydrochloride Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Folic Acid Injections Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Magnesium Chloride Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- CriticalGreen Valley Drugs Recalls Cyanocobalamin Injection Due to Sterility Failure
FDA (Drugs) · 2013-05-22
- SevereWells Pharmacy Recalls Methylcobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereVitalab Methylcobalamin Injection Recalled Due to Sterility Concerns
FDA (Drugs) · 2018-05-16
- SevereMedPark Pharmacy Recalls Methylcobalamin Injection Vials Due to Sterility Concerns
FDA (Drugs) · 2017-06-14
- SeverePromise Pharmacy Recalls Methylcobalamin Injections Due to Sterility Concerns
FDA (Drugs) · 2019-02-20
- SevereRed Mountain Compounding Recalls S-Methylcobalamin Injections for Sterility Concerns
FDA (Drugs) · 2019-11-13